STOCKHOLM, April 30,
2024 /PRNewswire/ -- Pixelgen
Technologies announced today the appointment of Mostafa Ronaghi, Ph.D., to its Scientific
Advisory Board. As a renowned genomicist and serial entrepreneur,
Ronaghi will support Pixelgen's continued commercial expansion and
product development roadmap for Molecular Pixelation, the
company's patented technology for high multiplex spatial analysis
of membrane proteins on single cells.
"Mostafa is a recognized life sciences visionary leader,
with deep expertise in genomics and a tested entrepreneurial
spirit," said Pixelgen CEO Simon
Fredriksson. "These attributes align well with Pixelgen's
mission and culture, and we are honored to have him on our board.
We look forward to working with him and to benefitting from his
valuable contributions."
Ronaghi is co-founder and executive board member
of Cellanome. Previously, he spent more than a decade at
Illumina, where he served on the executive team as chief technology
officer and senior vice president of entrepreneurial development.
Ronaghi co-founded GRAIL, a next-generation liquid biopsy company
for cancer detection, while at Illumina. Before that, he was a
principal investigator at Stanford
University's Genome Technology Center, where he focused on
the development of novel molecular diagnostics tools. A serial
entrepreneur, Ronaghi has founded numerous successful companies,
including Clear Labs, Aventome, NextBio, ParAllele Biosciences, and
Pyrosequencing AB.
"I'm thrilled to join Pixelgen's Scientific Advisory Board and
look forward to working with the company's impressive team to
continue developing Molecular Pixelation," Ronaghi said. "The
ability to better understand the spatial dynamics of the cell
surface proteome, at the individual cell level, in high resolution,
and in a multiplex manner is truly unique. I believe we are only
just beginning to understand the breadth of Molecular Pixelation's
potential applications and impact on drug development and
diagnostics."
Ronaghi joins Pixelgen's existing board of scientific experts,
including Emma Lundberg, visiting
associate professor at Stanford
University and professor at the KTH Royal Institute of
Technology; Petter Brodin, professor
at Imperial College London and professor at the Karolinska Institute; and Tarjei Mikkelsen, former
chief technology officer at Arsenal Bio.
About Pixelgen Technologies
Pixelgen Technologies AB was founded in 2020 by a team of
passionate, experienced innovators and entrepreneurs with a vision
to bring a new spatial understanding to biology by mapping cell
surface proteins and their spatial inter-relationships. The company
has developed Molecular Pixelation, a DNA-based visualization
technology for analyzing cell surface proteins, to gain novel
insights into cellular activity that will advance better medicines
and diagnostics. Pixelgen is headquartered in Stockholm, Sweden.
Contacts
Corporate:
Annika Branting
annika.branting@pixelgen.com
+46 762-69 68 46
Media:
Susan Thomas
susan@endpointcommunications.net
+1 (619) 540-9195
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pixelgen-technologies-appoints-mostafa-ronaghi-to-scientific-advisory-board-302131011.html
SOURCE Pixelgen Technologies